Search of the correlation berween anxiolytic effect of original derivative of pyrrolo [1,2-A] pyrazine TSPO-LIGAND (GML-1) and its concentrations in the rat blood plasma
Resume. Comparison of “concentration-effect” relation for a new potential anxiolytic drug GML-1, being TSPO Ligand was carried out. GML-1 was administered in rats once, intragastricaLLy in the dose 1 mg/kg. Tested drug concentrations in the rat bLood plasma and animaLs behavior in the test of “eLeva...
Saved in:
| Main Authors: | M. A. Yarkova, A. A. Litvin, G. B. Kolyvanov, V. P. Zherdev, S. B. Seredenin, V. I. Gegechkori |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2018-03-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/60 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of acute toxicity of potential anxiolytic GML-1
by: I. A. Miroshkina, et al.
Published: (2019-01-01) -
Development of the optimal scheme for the synthesis of the dipeptide TSPO ligand, N-phenylpropionyl-L-tryptophanyl-L-leucine amide (GD-102), a potential anxiolytic drug
by: O. A. Deeva
Published: (2024-01-01) -
Study of acute toxicity of the drug GML-1
by: A. V. Sorokina, et al.
Published: (2018-03-01) -
Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis
by: Nylund Marjo, et al.
Published: (2025-08-01) -
Approaches to predict ligands affinity towards translocator protein TSPO 18 kDa in order to create molecules possessing neuropsychotropic activity
by: N. M. Baraboshkin, et al.
Published: (2019-01-01)